The protective effect of arbutin against potassium bromate-induced oxidative damage in the rat brain

MakaleYalnız künyeScopus SJRQ2

Özet

This study aimed to investigate the protective effects of arbutin (ARB) against brain injury induced in rats with potassium bromate (KBrO3). The rats were divided into four groups as Group 1: Control (0.9% NaCl ml/kg/day p.), Group 2: KBrO3 (100 mg/kg (gavage), Group 3: ARB (50 mg/kg/day p.), and Group 4: KBrO3 + ARB (100 mg/kg (gavage) + 50 mg/kg/day p.). At the end of the fifth day of the study, the rats in all groups were killed, and their brain tissues were collected. In the collected brain tissues, malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT) levels were measured, and routine histopathological examinations were made. The MDA levels in the group that was exposed to KBrO3 were significantly higher than those in the control group (p ˂ 0.001). In comparison to the KBrO3 group, the MDA levels in the KBrO3 + ARB group were significantly lower (p ˂ 0.001). It was observed that SOD and CAT enzyme activity levels were significantly lower in the KBrO3 group compared to the control group (p ˂ 0.001), while these levels were significantly higher in the KBrO3 + ARB group than in the KBrO3 group (p ˂ 0.001). Additionally, the group that was subjected to KBrO3 toxicity, as well as ARB administration, had much lower levels of histopathologic signs than the group that was subjected to KBrO3 toxicity only. Consequently, it was found that KBrO3 exposure led to injury in the brain tissues of the rats, and using ARB was effective in preventing this injury.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/munzur/2396Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/jbt.23248Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
10
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAkkoyun, H. Turan
dc.contributor.authorUyar, Ahmet
dc.contributor.authorBayramoglu Akkoyun, Mahire
dc.contributor.authorBengü, Aydın Şükrü
dc.contributor.authorMelek, Şule
dc.contributor.authorKaragözoğlu, Fatma
dc.contributor.authorAydın, Sevinç
dc.contributor.authorEkin, Suat
dc.contributor.authorErdem, Sinem Aslan
dc.date.accessioned2026-10-28T14:55:19.159317224Z
dc.date.available2026-10-28T14:55:19.159317224Z
dc.date.issued2023
dc.description.abstractThis study aimed to investigate the protective effects of arbutin (ARB) against brain injury induced in rats with potassium bromate (KBrO3). The rats were divided into four groups as Group 1: Control (0.9% NaCl ml/kg/day p.), Group 2: KBrO3 (100 mg/kg (gavage), Group 3: ARB (50 mg/kg/day p.), and Group 4: KBrO3 + ARB (100 mg/kg (gavage) + 50 mg/kg/day p.). At the end of the fifth day of the study, the rats in all groups were killed, and their brain tissues were collected. In the collected brain tissues, malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT) levels were measured, and routine histopathological examinations were made. The MDA levels in the group that was exposed to KBrO3 were significantly higher than those in the control group (p ˂ 0.001). In comparison to the KBrO3 group, the MDA levels in the KBrO3 + ARB group were significantly lower (p ˂ 0.001). It was observed that SOD and CAT enzyme activity levels were significantly lower in the KBrO3 group compared to the control group (p ˂ 0.001), while these levels were significantly higher in the KBrO3 + ARB group than in the KBrO3 group (p ˂ 0.001). Additionally, the group that was subjected to KBrO3 toxicity, as well as ARB administration, had much lower levels of histopathologic signs than the group that was subjected to KBrO3 toxicity only. Consequently, it was found that KBrO3 exposure led to injury in the brain tissues of the rats, and using ARB was effective in preventing this injury.
dc.identifier.articlenumbere23248
dc.identifier.doi10.1002/jbt.23248
dc.identifier.eissn1099-0461
dc.identifier.issn1095-6670
dc.identifier.issue2
dc.identifier.pmid36284482
dc.identifier.scopus2-s2.0-85140376366
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/munzur/2396
dc.identifier.volume37
dc.identifier.wosWOS:000871772200001
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofJournal of Biochemical and Molecular Toxicology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectarbutin (β-d-glucopyranoside, 4-hydroxyphenyl)
dc.subjectcatalase (CAT)
dc.subjectmalondialdehyde (MDA)
dc.subjectpotassium bromate (KBrO<sub>3</sub>)
dc.subjectsuperoxide dismutase (SOD)
dc.subject.otherAngiotensin Receptor Antagonists
dc.subject.otherAngiotensin-Converting Enzyme Inhibitors
dc.subject.otherAnimals
dc.subject.otherAntioxidants
dc.subject.otherArbutin
dc.subject.otherBrain
dc.subject.otherLipid Peroxidation
dc.subject.otherOxidative Stress
dc.subject.otherRats
dc.subject.otherSuperoxide Dismutase
dc.subject.othercatalase
dc.subject.othermalonaldehyde
dc.subject.otherpotassium bromate
dc.subject.othersodium chloride
dc.subject.otherangiotensin receptor antagonist
dc.subject.otherantioxidant
dc.subject.otherdipeptidyl carboxypeptidase inhibitor
dc.subject.otheranimal experiment
dc.subject.otheranimal model
dc.subject.otheranimal tissue
dc.subject.otherantioxidant activity
dc.subject.otherArticle
dc.subject.otherbrain injury
dc.subject.otherbrain lateral ventricle
dc.subject.otherbrain necrosis
dc.subject.otherbrain tissue
dc.subject.otherchoroid plexus
dc.subject.othercontrolled study
dc.subject.otherenteric feeding
dc.subject.otherenzyme activity
dc.subject.othergliosis
dc.subject.otherhippocampus
dc.subject.otherhistopathology
dc.subject.otherhyperemia
dc.subject.othermale
dc.subject.othernerve cell
dc.subject.othernerve cell degeneration
dc.subject.otherneuroprotection
dc.subject.othernonhuman
dc.subject.otherpyramidal nerve cell
dc.subject.otherrat
dc.subject.otheranimal
dc.subject.othermetabolism
dc.titleThe protective effect of arbutin against potassium bromate-induced oxidative damage in the rat brain
dc.typeArticle
rdl.citation.scopus10
rdl.departmentDepartment of Physiology, Faculty of Veterinary Medicine, Siirt University, Siirt, Turkey
rdl.departmentDepartment of Pathology, Faculty of Veterinary Medicine, Hatay Mustafa Kemal University, Hatay, Turkey
rdl.departmentDepartment of Biochemistry, Faculty of Veterinary Medicine, Siirt University, Siirt, Turkey
rdl.departmentDepartment of Medical Services and Technics, Vocational School of Health, Bingöl University, Bingöl, Turkey
rdl.departmentDepartment of Surgery, Faculty of Veterinary Medicine, Bingöl University, Bingöl, Turkey
rdl.departmentDepartment of Zootechnique and Animal Nutrition, Faculty of Veterinary Medicine, Bingöl University, Bingöl, Turkey
rdl.departmentÇemişgezek Vocational School, Munzur University, Tunceli, Turkey
rdl.departmentDepartment of Chemistry, Faculty of Science, Van Yüzüncü Yıl University, Van, Turkey
rdl.departmentDepartment of Pharmacognosy, Faculty of Pharmacy, Ankara University, Ankara, Turkey
rdl.oa.statusclosed
rdl.scopus.quartileQ2
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED